1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. CADRENAL THERAPEUTICS INC

Cadrenal Therapeutics Inc

XNAS: CVKD

Download real time

19.50 -0.02 (-0.10%)

5316.67% Gain from 52W Low

27,566 XNAS Volume

XNAS 20 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
12S
6W
5O
0T
36.7

Market Cap

Below industry Median
-3.4

PE TTM

Negative PE TTM
0.1

PEG TTM

PEG TTM is less than 1
10.2

Price to Book

High in industry
-0.8

Beta 1Year

Very Low volatility


Insider Trading disclosures for Cadrenal Therapeutics Inc

The latest disclosure was made by Jeffrey Cole in Cadrenal Therapeutics Inc where a trade of 25,000 Stock Options done was reported to US exchanges on Jan. 23, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Jeffrey Cole Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2025 25,000 25,000 - - Stock Options
Quang X. Pham Director, CEO and Chairman, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2025 65,000 65,000 - - Stock Options
Robert Lisicki Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2025 20,000 20,000 - - Stock Options
Steven Zelenkofske Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2025 20,000 20,000 - - Stock Options
Glynn Wilson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2025 20,000 20,000 - - Stock Options
Matthew K. Szot Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2025 50,000 50,000 - - Stock Options
John Raymond Murphy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jan 2025 20,000 20,000 - - Stock Options
Quang X. Pham Director, CEO and Chairman, Ten Percent Owner Gift of securities by or to the insider at price $ 0.00 per share. 10 Apr 2024 50,000 3,275,000 - 0 Common Stock
Jeffrey Cole Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Apr 2024 150,000 150,000 - - Stock Options
Matthew K. Szot Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jan 2024 250,000 250,000 - - Stock Options
Robert Lisicki Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jan 2024 50,000 50,000 - - Stock Options
Douglas Losordo W. Chief Medical Officer 18 Jan 2024 150,000 150,000 - - Stock Options
Pham Quang X. Director, Chief Executive Officer, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jan 2024 150,000 150,000 - - Stock Options
Steven Zelenkofske Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jan 2024 100,000 100,000 - - Stock Options
Glynn Wilson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jan 2024 70,000 70,000 - - Stock Options
Raymond Murphy John Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jan 2024 100,000 100,000 - - Stock Options
Quang X. Pham Director, CEO and Chairman, Ten Percent Owner Gift of securities by or to the insider at price $ 0.00 per share. 23 Oct 2023 85,000 3,325,000 - 0 Common Stock
John Murphy Raymond Director Purchase of securities on an exchange or from another person at price $ 0.70 per share. 04 Oct 2023 17,331 612,123 - 0.7 12,132 Common Stock
Raymond Murphy John Director Purchase of securities on an exchange or from another person at price $ 0.69 per share. 04 Oct 2023 2,669 614,792 - 0.7 1,842 Common Stock
Robert Lisicki Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jul 2023 75,000 75,000 - - Stock options
John Raymond Murphy Director Purchase of securities on an exchange or from another person at price $ 1.39 per share. 21 Mar 2023 10,000 594,792 - 1.4 13,900 Common Stock
John Raymond Murphy Director Purchase of securities on an exchange or from another person at price $ 1.67 per share. 16 Mar 2023 20,000 574,792 - 1.7 33,398 Common Stock
Quang X. Pham Director, CEO and Chairman, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 1.94 per share. 10 Feb 2023 25,000 3,300,000 - 1.9 48,500 Common Stock
Matthew K. Szot Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2023 50,000 500,000 - 0 Common Stock
Glynn Wilson Director 24 Jan 2023 50,000 50,000 - - Common Stock
John Raymond Murphy Director 24 Jan 2023 514,792 0 - - Convertible Promissory Note
Glynn Wilson Director 24 Jan 2023 50,000 0 - - Convertible Promissory Note
John Raymond Murphy Director 24 Jan 2023 514,792 554,792 - - Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters